Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/24921
Başlık: Postoperative concomitant chemoradiotherapy in locally advanced rectal cancer
Yazarlar: Uludağ Üniversitesi/Tıp Fakültesi/Radyasyon Onkolojisi Anabilim Dalı.
Uludağ Üniversitesi/Tıp Fakültesi/Cerrahi Anabilim Dalı.
Uludağ Üniversitesi/Tıp Fakültesi/Biyoistatistik Anabilim Dalı.
Uludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Anabilim Dalı.
0000-0003-1637-910X
0000-0002-2382-290X
Kurt, Meral
Özkan, Lütfi
Yılmazlar, Tuncay
Ercan, İlker
Zorluoǧlu, Abdullah
Memik, Faruk
Engin, Kayıhan
AAA-3961-2020
8843050600
55915679400
6701800362
6603789069
6602076843
6701813462
6701768798
Anahtar kelimeler: Gastroenterology & hepatology
Surgery
Postoperative
Chemoradiotherapy
Rectal cancer
Preoperative infusional chemoradiation
Radiation-therapy
Colorectal-cancer
Adjuvant therapy
Distal rectum
Adenocarcinoma
Radiotherapy
Carcinoma
Resection
Yayın Tarihi: 2005
Yayıncı: H G E Update Medical Publishing
Atıf: Kurt, M. vd. (2005). "Postoperative concomitant chemoradiotherapy in locally advanced rectal cancer". Hepato-Gastroenterology, 52(65), 1411-1415.
Özet: Background/Aims: To gain maximal effectiveness while decreasing toxicity by giving 5-fluorouracil for 45 minutes starting just within 5 minutes after the completion of radiotherapy thrice weekly. Methodology: Thirty-eight patients with locally advanced rectal cancer were enrolled in the study. Ranges of total radiation doses were between 50.4 Gy and 61.2 Gy with a median of 59.4 Gy with fraction size of 1.8 Gy five times weekly. 5-fluorouracil was administered thrice weekly with the dose of 250300mg/m(2)/day concomitantly with radiation therapy. Results: Median follow-up time was 30 months. Administration of chemotherapy concomitant with radiotherapy (p=0.089), AJCC stage III (p=0.079), Duke's stage C (p=0.079), presence of lymph node involvement (p=0.079) and presence of local recurrence (p=0.066) appeared to be effecting distant metastasis although differences did not reach statistically significance. Mean overall survival was 46 months in patients without any distant metastasis (SD: 3.28; 95% CI: 39.46 and 52.31) while it was 35 months in patients with distant metastasis (SD: 5.71; 95% CI: 23.52 and 45.90, p = 0.0 16). Conclusions: Our results have provided further evidence of the ability of postoperative chemoradiotherapy to delay and prevent local recurrence and metastasis of rectal cancer.
URI: http://hdl.handle.net/11452/24921
ISSN: 0172-6390
Koleksiyonlarda Görünür:PubMed
Scopus
Web of Science

Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.


DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.